SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-007605
Filing Date
2012-08-02
Accepted
2012-08-02 16:11:03
Documents
14
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pdl_10q-063012.htm 10-Q 1212386
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 693870
3 EXHIBIT 12.1 ex12-1.htm EX-12.1 45141
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 12195
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 12230
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 6697
7 EXHIBIT 32.2 ex32-2.htm EX-32.2 6437
14 logo.jpg GRAPHIC 23080
  Complete submission text file 0001437749-12-007605.txt   9878681

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE pdli-20120630.xml EX-101.INS 1836921
9 XBRL TAXONOMY EXTENSION SCHEMA pdli-20120630.xsd EX-101.SCH 64633
10 XBRL TAXONOMY EXTENSION CALCULATION pdli-20120630_cal.xml EX-101.CAL 43962
11 XBRL TAXONOMY EXTENSION DEFINITION pdli-20120630_def.xml EX-101.DEF 335276
12 XBRL TAXONOMY EXTENSION LABELS pdli-20120630_lab.xml EX-101.LAB 393296
13 XBRL TAXONOMY EXTENSION PRESENTATION pdli-20120630_pre.xml EX-101.PRE 337607
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 121003575
SIC: 2836 Biological Products, (No Diagnostic Substances)